False detection of rifampicin resistance using Xpert® MTB/RIF Ultra assay due to an A451V mutation in Mycobacterium tuberculosis.
Margaret M FitzgibbonEmma RoycroftGerard SheehanAnne-Marie Mc LaughlinKeith Ian QuintyneElaine BrabazonMary O'MearaPeter R FlanaganA-Louise SeagarIan F LaurensonJoseph KeaneThomas R RogersPublished in: JAC-antimicrobial resistance (2021)
False detection of rifampicin resistance, albeit rare, should be considered possible with Xpert® MTB/RIF Ultra assay, particularly in low TB incidence settings. Confirmatory sequencing methods should be performed to prevent the unnecessary use of second-line anti-tuberculous drugs.